OCM
FRLN

Ovata Capital Management’s Freeline Therapeutics Holdings plc American Depositary Shares FRLN Stock Holding History

Ovata Capital Management’s Portfolio FRLN Stock Details FRLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-999
Closed -$274K – 68
2020
Q4 		$274K Sell
999
-1,501
-60% -$377K 0.09% 41
2020
Q3 		$585K Buy
+2,500
New +$627K 0.21% 41

Other funds holding FRLN

EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $515M AUM 24.47% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
ABG
Ally Bridge Group New York $124M AUM 249.88% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Ovata Capital Management's FRLN Position: Q1 2021 in Review

Ovata Capital Management sold out of Freeline Therapeutics Holdings plc American Depositary Shares (FRLN) in Q1 2021, closing a stake of 999 shares — an estimated $274K sold.

Ovata Capital Management first reported a position in FRLN in Q3 2020 and held it in 2 quarters. The position peaked at $585K in Q3 2020. 19 funds tracked by Wall St. Rank hold FRLN as of Q1 2021.

  • Ovata Capital Management reported no remaining Freeline Therapeutics Holdings plc American Depositary Shares position as of Q1 2021 after selling out during the quarter.
  • Ovata Capital Management sold 999 Freeline Therapeutics Holdings plc American Depositary Shares shares in Q1 2021, an estimated $274K.
  • Ovata Capital Management first reported a position in Freeline Therapeutics Holdings plc American Depositary Shares in Q3 2020 and held it in 2 quarters.
  • Ovata Capital Management's Freeline Therapeutics Holdings plc American Depositary Shares position peaked at $585K in Q3 2020.
  • 19 funds tracked by Wall St. Rank held Freeline Therapeutics Holdings plc American Depositary Shares as of Q1 2021.

Based on Ovata Capital Management's 13F filing for Q1 2021, filed 17 May 2021.